Why are doctors not moving to second-generation basal insulins?

Second-generation basal insulins are particularly beneficial to diabetes patients with marked variability in glucose levels, frequent all-day and/or nocturnal hypoglycaemia despite optimisation of current insulin analogue regimen

Learning objectives

  • To establish the importance of glucose control over time to reduce microvascular and macrovascular complications
  • To encourage the use of continuous glucose monitoring (CGM), even for briefer periods of time (3/4 days) to assess time-in-range and glucose variability more accurately in an individual patient
  • To ensure that both T2DM and T1DM patients receive the best basal insulin with comprehensive 24-hour coverage and a reduced incidence of hypoglycaemia, particularly at night.

 

To access this module, please register or login: